Speciality European Pharma (SEP) is a privately owned, specialist pharmaceutical company with a key focus on urology. SEP work throughout Europe and beyond to market and improve its products available to treat urological conditions. SEP’s goal is to become Europe’s leading specialist urology focused pharmaceutical company through organic development of its existing product portfolio and through further acquisitions and licensing. SEP aims to be considered the partner of choice for companies seeking to register and market their urology products in Europe. Caution: Aquamid(R) and Bulkamid(R) are investigational devices in the United States and limited by Federal (or United States) law to investigational use. They are not available for sale in the United States. More information: info@spepharma.com